Boehringer Ingelheim continues to believe in the value that flibanserin would have for women suffering with HSDD. Company will still complete the two most advanced clinical studies. Ingelheim (Germany ...
This Friday, the U.S. Food and Drug Administration will hear from an expert panel about the merits of, flibanserin, a drug that has been touted as potentially being the female equivalent of Viagra.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback